01391nas a2200241   4500000000100000008004100001260001200042653001500054653001400069653001200083653001500095653001200110100001300122700001300135700001100148700001200159700001200171245007800183856004500261490000600306520082300312022001401135       2021                            d  c01/202110abiomarkers10adiagnosis10aleprosy10aproteomics10avaccine1 aGautam S1 aSharma D1 aGoel A1 aPatil S1 aBisht D00aInsights into Mycobacterium leprae Proteomics and Biomarkers-An Overview.  uhttps://www.mdpi.com/2227-7382/9/1/7/htm0 v93 a<p>Although leprosy is curable, the identification of biomarkers for the early diagnosis of leprosy would play a pivotal role in reducing transmission and the overall prevalence of the disease. Leprosy-specific biomarkers for diagnosis, particularly for the paucibacillary disease, are not well defined. Therefore, the identification of new biomarkers for leprosy is one of the prime themes of leprosy research. Studying , the causative agent of leprosy, at the proteomic level may facilitate the identification, quantification, and characterization of proteins that could be potential diagnostics or targets for drugs and can help in better understanding the pathogenesis. This review aims to shed light on the knowledge gained to understand leprosy or its pathogen employing proteomics and its role in diagnosis.</p>  a2227-7382